Oregon Enacts Ryan’s Law to Expand Medical Cannabis Access in Hospice Care Despite Low Uptake

Oregon has enacted Ryan's Law, mandating that hospice and palliative care facilities permit qualified patients to use medical cannabis. This legislation ensures greater access for individuals seeking comfort and symptom management during end-of-life care, directly impacting patient quality of life. The law also establishes hospice or palliative care as a new qualifying condition for medical cannabis use, thereby broadening eligibility for the Oregon Medical Marijuana Program (OMMP).

This new law requires specified providers, including hospice and residential care facilities, to implement detailed policies and staff training for the safe administration of cannabis within their premises. This crucial step aims to create a standardized and compliant environment for medical cannabis use, moving beyond previous ambiguities.

The foundation for this access was initially laid by a 2025 bill. That legislation permitted OMMP patients to designate a hospice, palliative care provider, home health agency, or residential facility as an organizational caregiver. The intent was to integrate medical cannabis more seamlessly into comprehensive care plans for seriously ill individuals.

However, the practical uptake of this organizational caregiver program remained notably low. As of January 2025, the Oregon Health Authority recorded only one designated organizational caregiver statewide, serving a total of eight patients. This statistic highlighted a significant discrepancy between the legal framework and its on-the-ground implementation, indicating that existing procedures lacked sufficient clarity or enforcement for widespread adoption.

Representative Farrah Chaichi, a primary sponsor of Ryan's Law, articulated the bill's core intent during its passage. She stated that medical cannabis offers patients a vital alternative or supplement to traditional opioid medications. Opioids, while effective for pain, often induce excessive sedation, thereby limiting a patient's ability to engage with family and friends during their final days. The law prioritizes enhanced patient presence and interaction over deep sedation, aiming for improved end-of-life experience.

Ryan's Law specifically addresses the observed gaps in prior legislation by providing clearer responsibilities and establishing a more robust structure for facilities and healthcare professionals. Its objective is to significantly boost participation in the OMMP for end-of-life patients, ensuring their right to choose cannabis as part of their care is both respected and effectively implemented within care settings. This proactive approach seeks to overcome previous hurdles in policy adoption and training, moving from intent to practical reality.

Future observation will focus on key metrics: the increase in the number of designated organizational caregivers and the expansion of the total patient count served by the program under this new mandate. Monitoring these figures will indicate the law's effectiveness in broadening medical cannabis access for hospice and palliative care patients across Oregon, assessing its impact on patient choice and care provision.